Research conducted by the Maryland ADHD Program focuses broadly on comprehensive behavioral and combined behavioral/pharmacological treatments for ADHD and specifically on the impact of parental psychopathology on developmental and treatment outcomes of children with ADHD. Ongoing program-wide projects include: (1) an NIMH-funded study examining associations between maternal ADHD symptoms, parenting, and participation in child behavioral treatment; (2) in collaboration with Children’s National Medical Center, a study funded by Mc Neil Consumer & Specialty Pharmaceuticals examining the efficacy of Concerta™ methylphenidate in improving parenting in ADHD mothers of children with ADHD; (3) an NIMH-funded study developing and evaluating an integrated behavioral intervention for depressed mothers of children with ADHD; and (4) in collaboration with Nathan Fox in the Department of Human Development, a NIMH-funded longitudinal study examining early temperamental predictors of adolescent psychopathology. Additionally, current graduate student research examines the efficacy of teacher inservice training in evidence-based assessment and treatment of ADHD, the efficacy of a homework intervention for middle school students with ADHD, and the relationship between parenting and disruptive behavior disorders in Latino families.
The Center for Addictions, Personality, and Emotion Research (CAPER) is focused on the use of basic experimental methodologies to elucidate the mechanisms underlying the development and maintenance of addictive behaviors, mood disturbances, and cluster B personality disorders (e.g., borderline, antisocial), as well as the application of this research to the development of novel clinical assessment and treatment strategies. Headed by Dr. Lejuez, core faculty also include Dr. Stacey Daughters (director of addictions research), Dr. Kim Gratz (director of personality disorders research), and Dr. Matthew Tull (director of basic emotion research), as well as 9 graduate and 6 undergraduate students. The lab is currently funded with 3 R01 grants from the National Institute on Drug Abuse (NIDA) with projects focused on 1) risk taking in inner-city adolescents, 2) biobehavioral assessment technologies to understand vulnerabilities to early smoking lapse, and 3) the development of a novel treatment for depressed smokers. Additional funding includes an R03 also from NIDA to Dr. Daughters to study predictors of treatment dropout for heroin and crack/cocaine users in residential drug treatment, 2 individual NRSA awards on risk taking in adolescents and risky sexual behavior as a function of drug choice among crack/cocaine and heroin users, and 2 minority supplements. Future projects include the development of fully functioning clinics for the treatment of addictions and personality disorders.
Clinical Psychology Program • Department of Psychology • University
of Maryland
College Park, Maryland 20742-4411 • phone: 301-405-5890 • fax:
301-314-9566 • email: jcoldren@psyc.umd.edu